Yaccarino, who has a house in Woodbury, graduated from Deer Park High in 1981 with her twin sister, Lori. Both were elected ...

Even though Novo Nordisk warned that copycat versions of its obesity and diabetes drugs would hurt sales in the U.S., second-quarter sales saw a 67% rise year on year. More news covers telehealth ...

There is an opportunity to combine technology, lifestyle, and data in a new powerful way through the digital channels that ...

President Trump threatened 250% tariffs on pharma; Pfizer CEO contacted Trump about most favored nation pricing; Ex-X CEO joins eMed.

Yaccarino will be CEO of a unit at the company, which focuses on patients taking weight-management and diabetes medications.

Yaccarino has been named CEO of Miami-based eMed Population Health, which calls itself “the leading digital health platform ...

Linda Yaccarino, the former X CEO who left the social media company in the wake of yet another Elon Musk controversy, has ...

Last Friday, the day after Figma went public with a 250% pop, former Federal Trade Commission Chair Lina Khan tweeted that ...

Vertex Pharmaceuticals Inc. fell after an experimental pain drug failed to provide post-surgery benefits and US regulators ...

The Santa Clara, Calif., chip maker logged an increase in profit and sales for its latest quarter on record server and personal computer processor sales. Fifteen of the biotechnology company's ...

Former X CEO Linda Yaccarino said Tuesday she has taken on a new role leading a digital health platform, less than a month ...

Hims & Hers Health posted an increase in profit and revenue for the second quarter on growth in subscribers using personalized treatment plans. The telehealth-consultation platform on Monday posted a ...